Sign in
4/A

Changes in Ownership

Faeth Therapeutics, Inc. Filed Acc 0001567619-22-008798

10% owner bought 752 shares at $19.75 ($14,852)

From the SEC's structured data for this filing

Trades in this filing

Cambrian BioPharma Inc · 10% owner

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-02-18 Purchase : show line 1 in the form +752 $19.75 $14,852 4,690,905 D
Open-market purchases · 752 sh · avg $19.75 · $14,852
Loading xslF345X03/doc1.xml…